CA2290781A1 - Antimicrobial peptide - Google Patents

Antimicrobial peptide Download PDF

Info

Publication number
CA2290781A1
CA2290781A1 CA002290781A CA2290781A CA2290781A1 CA 2290781 A1 CA2290781 A1 CA 2290781A1 CA 002290781 A CA002290781 A CA 002290781A CA 2290781 A CA2290781 A CA 2290781A CA 2290781 A1 CA2290781 A1 CA 2290781A1
Authority
CA
Canada
Prior art keywords
seq
sequence
amino acids
polypeptide
antimicrobial peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002290781A
Other languages
English (en)
French (fr)
Inventor
Henrik S. Olsen
Steven M. Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2290781A1 publication Critical patent/CA2290781A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002290781A 1997-05-14 1998-05-14 Antimicrobial peptide Abandoned CA2290781A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4641597P 1997-05-14 1997-05-14
US60/046,415 1997-05-14
PCT/US1998/009796 WO1998051794A1 (en) 1997-05-14 1998-05-14 Antimicrobial peptide

Publications (1)

Publication Number Publication Date
CA2290781A1 true CA2290781A1 (en) 1998-11-19

Family

ID=21943326

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002290781A Abandoned CA2290781A1 (en) 1997-05-14 1998-05-14 Antimicrobial peptide

Country Status (8)

Country Link
US (3) US6143498A (enExample)
EP (1) EP0980431A1 (enExample)
JP (1) JP2001527412A (enExample)
KR (1) KR20010012554A (enExample)
CN (1) CN1260834A (enExample)
AU (1) AU737710B2 (enExample)
CA (1) CA2290781A1 (enExample)
WO (1) WO1998051794A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984622B2 (en) * 1998-03-25 2006-01-10 The Regents Of The University Of California Use of lipopolysaccharides to manage corneal infections and wounds
AU7725500A (en) * 1999-09-30 2001-04-30 National Jewish Medical And Research Center Method for inhibition of pathogenic microorganisms
ATE319740T1 (de) * 2000-06-08 2006-03-15 Ipf Pharmaceuticals Gmbh Verfahren zur gewinnung und anwendung von antibiotisch wirksamen peptiden zur behandlung von infektionskrankheiten
US6846804B2 (en) * 2000-06-29 2005-01-25 University Of Maryland, College Park Office Of Technology Commercialization Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as bacillus anthrasis
DE10129983A1 (de) * 2001-06-13 2003-01-30 Univ Eberhard Karls Antimikrobiell wirkendes Peptid
US8329865B2 (en) * 2001-06-13 2012-12-11 Eberhard-Karls-Univresitaet Tuebingen Universitaetsklinikum Antimicrobially active peptides
US7507787B2 (en) * 2001-12-03 2009-03-24 The University Of British Columbia Effectors of innate immunity
AU2003215257A1 (en) 2002-02-19 2003-09-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Modified defensins and their use
DE60335101D1 (de) 2002-04-25 2011-01-05 Toagosei Co Ltd Antimikrobielles polypeptid und nutzung davon
US7033769B2 (en) * 2002-05-23 2006-04-25 The United States Of America As Represented By The Secretary Of The Army Method for discovering one or more peptides adapted for specific binding to a microorganism of interest
JP4524671B2 (ja) 2003-10-29 2010-08-18 東亞合成株式会社 抗菌ペプチド及びその利用
JP4507080B2 (ja) 2004-07-30 2010-07-21 東亞合成株式会社 抗菌ペプチド及びその利用
JP4730584B2 (ja) 2004-12-06 2011-07-20 東亞合成株式会社 抗菌ペプチド及びその利用
WO2006083927A2 (en) * 2005-01-31 2006-08-10 Coram Bioscience, Inc. Antimicrobial agent
WO2006088010A1 (ja) 2005-02-15 2006-08-24 Toagosei Co., Ltd. 抗菌ペプチド及びその利用
US20070231833A1 (en) * 2005-05-23 2007-10-04 Arcidiacono Steven M Labeled antimicrobial peptides and method of using the same to detect microorganisms of interest
EP2010561A4 (en) * 2006-04-27 2010-03-24 Singapore Health Services Pte ANTIMICROBIAL PEPTIDES
US20100150985A1 (en) * 2008-04-24 2010-06-17 George Just Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same
FR2944019B1 (fr) * 2009-04-03 2011-04-22 Biomerieux Sa Procede de dosage de la prodefensine-a6 pour le diagnostic in vitro du cancer colorectal.
WO2011137368A2 (en) 2010-04-30 2011-11-03 Life Technologies Corporation Systems and methods for analyzing nucleic acid sequences
US9268903B2 (en) 2010-07-06 2016-02-23 Life Technologies Corporation Systems and methods for sequence data alignment quality assessment
KR101303299B1 (ko) * 2010-10-08 2013-09-03 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 항균 펩타이드의 피부 세포 재생 촉진제로서의 신규한 용도
US10967031B2 (en) 2010-12-28 2021-04-06 Kamedis Ltd. Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation
CN103533947A (zh) 2010-12-28 2014-01-22 卡梅迪斯有限公司 用于治疗和预防感染的植物提取物
US10160793B2 (en) 2013-03-15 2018-12-25 Genentech, Inc. Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins
US11612225B2 (en) * 2018-05-03 2023-03-28 Nicholas Schwartz Securing beach net
CN115428088A (zh) 2020-02-13 2022-12-02 10X基因组学有限公司 用于基因表达和dna染色质可及性的联合交互式可视化的系统和方法
EP4121087A4 (en) 2020-03-18 2024-04-03 The University of Hong Kong ANTI-VIRAL PEPTIDE COMPOSITIONS AND METHODS OF USE
WO2023125432A1 (en) * 2021-12-27 2023-07-06 Versitech Limited Antiviral peptides and methods of use thereof
CN116496916A (zh) * 2022-12-27 2023-07-28 安徽斯拜科生物科技有限公司 一种高产hbd-2的毕赤酵母工程菌株及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432270A (en) * 1990-10-25 1995-07-11 Zasloff; Michael A. DNA encoding tracheal antimicrobial peptides
AU670108B2 (en) 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
US5470955A (en) 1993-02-02 1995-11-28 Dartmouth College Antibodies which specifically bind mcl-1 polypeptide
DE4427531A1 (de) * 1994-08-04 1996-02-08 Forssmann Wolf Georg Humanes zirkulierendes beta-Defensin hBD-1
JP4001383B2 (ja) * 1995-12-16 2007-10-31 プラントン・ゲゼルシヤフト・ミット・ベシュレンクテル・ハフツング 細菌、菌類、およびウイルスに対して有効で、かつ脊椎動物性蛋白質を含む化粧用製剤
DE19629119A1 (de) * 1995-12-16 1997-06-19 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame kosmetische Zubereitungen enthaltend Vertebratenproteine

Also Published As

Publication number Publication date
US20050004355A1 (en) 2005-01-06
KR20010012554A (ko) 2001-02-15
AU7385898A (en) 1998-12-08
US6420116B1 (en) 2002-07-16
WO1998051794A1 (en) 1998-11-19
JP2001527412A (ja) 2001-12-25
US6143498A (en) 2000-11-07
AU737710B2 (en) 2001-08-30
EP0980431A1 (en) 2000-02-23
US7223840B2 (en) 2007-05-29
CN1260834A (zh) 2000-07-19

Similar Documents

Publication Publication Date Title
US7223840B2 (en) Antimicrobial peptide
WO1998033920A2 (en) Tissue factor pathway inhibitor-3
CA2268022A1 (en) Galectin 8, 9, 10 and 10sv
CA2280229A1 (en) Breast cancer specific gene 1
AU750170B2 (en) Caspase-14 polypeptides
US20030004327A1 (en) Cerebellum and embryo specific protein
CA2278349A1 (en) I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis
US6232100B1 (en) Cortistatin Polypeptides
US6929921B2 (en) Antibody which binds human blue-light photoreceptor hCRY2
WO1998053069A2 (en) Gdnf receptors
WO1998029438A9 (en) Cortistatin polypeptides
US7109306B2 (en) Antibodies to human oncogene induced secreted protein I
JPH10327881A (ja) 分泌マウスタンパク質ｓＦＲＰ−１に類似した新規ヒト 遺伝子
AU734384B2 (en) Apoptosis inducing molecule II
US20020132304A1 (en) Human parotid secretory protein
AU5988801A (en) Antimicrobial peptide
NZ513514A (en) Antimicrobial peptide
NZ500864A (en) Isolated nucleic acid molecules encoding human defensin peptide
AU4387701A (en) Apoptosis inducing molecule II
AU2004202460A1 (en) Apoptosis Inducing Molecule II

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead